CD4 and neoplasm: We observed infiltration of CD4+ and CD8+ T cells, increased CD8+ T cell and NK cell activation, and exclusion of pro-tumor M2 macrophages and mononuclear myeloid-derived suppressor cells (M-MDSCs) in tumors treated with therapeutic antibody as analyzed by flow cytometry (Figure 4C).